PARP Inhibitors for Cancer Therapy

Discover the groundbreaking insights in PARP Inhibitors for Cancer Therapy by Nicola J. Curtin, published by Birkhauser Verlag AG in 2018. This essential softcover reprint of the original 1st edition from 2015 spans an impressive 591 pages, offering a thorough exploration of the critical role of PARP in cancer treatment.

Delve into the mechanisms by which PARP contributes to DNA repair and understand its significant impact on therapeutic resistance to DNA-damaging agents commonly used in oncology. This book serves as a vital resource for researchers, clinicians, and students alike, providing the knowledge needed to navigate the complexities of cancer therapy and the potential of PARP inhibitors.

Enhance your understanding of modern cancer treatments with this comprehensive guide that is both informative and engaging.